Multiple Sclerosis Program
Neurologists at the University of Chicago Medicine Multiple Sclerosis Program are dedicated to improving the quality of life for people with multiple sclerosis (MS). Our doctors have helped to develop many of the life-transforming treatments currently used to treat MS. We have a distinguished record of providing definitive diagnoses and comprehensive treatments to help patients manage their symptoms and to limit flare-ups and progression of the disease. Our multidisciplinary team will determine the best treatment for symptoms of MS for every patient.
What is Multiple Sclerosis?
Multiple sclerosis is a chronic, autoimmune disease of the brain and spinal cord. While the exact cause is not known, we do know that MS causes a person's white blood cells to attack their myelin, the insulator of nerve fibers in the brain. This attack damages brain cells and interrupts nerve impulses that travel to and from the brain and spinal cord. Symptoms — often unpredictable and erratic — range from mild to severe, affect different parts of the brain, vary by patient and can often be treated.
- Blurred vision
- Progressive leg weakness
- Problems with bowel, bladder and sexual function
- Trigeminal neuralgia, a condition that causes sudden, severe facial pain
- Spastic movements and uncoordinated
Due to the complex and varying nature of MS, experience in treating and researching the disease is a key to determining the best treatments. Neurologists at UChicago Medicine have a long history of expert clinical care and research in multiple sclerosis. The UChicago Medicine physicians who treat multiple sclerosis patients are the same ones who research the causes and mechanisms of MS, develop effective treatments for the disease, and are actively searching for a cure.
Multiple Sclerosis Research
Neurologists at UChicago Medicine are always studying new ways to diagnose and treat multiple sclerosis, and have consistently been at the forefront of advancements in autoimmune diseases. In 1993, our researchers helped develop and test interferon, the first FDA-approved treatment for multiple sclerosis. This disease-modifying therapy reduces exacerbations, improves many functions — including memory — and improves life expectancy for MS patients by up to 10 years, allowing patients to live their natural life span. In the past three decades, many new medications, often developed and tested by our doctors, have been approved for relapsing and for progressive disease. In addition to offering these therapies, our team is directly involved in new clinical trials for the next generation of multiple sclerosis medications and diagnostic tools.
Translating MS Research from 'Bench to Bedside'
Our specialists are dedicated to translating biomedical discoveries from laboratory findings to innovative therapies. Because the physicians at the UChicago Medicine Multiple Sclerosis Clinic are the same research scientists leading the search for a cure, they bring a unique understanding of complex treatments to patient care. In addition to having access to the latest medications, they understand which treatment option is best for each course of MS and, through a personalized approach to care, can identify the best therapy for each patient.
You can also make an appointment with our providers by:
– Scheduling a virtual video visit to see a provider from the comfort of your home
– Requesting an online second opinion from our specialists
To speak to someone directly, please call 1-773-702-6222. If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.
* Required Field
Chicago, IL 60637 888-824-0200